U.S. markets open in 1 hour 4 minutes
  • S&P Futures

    4,147.50
    -21.50 (-0.52%)
     
  • Dow Futures

    34,130.00
    -188.00 (-0.55%)
     
  • Nasdaq Futures

    13,302.25
    -84.75 (-0.63%)
     
  • Russell 2000 Futures

    2,200.10
    -22.60 (-1.02%)
     
  • Crude Oil

    64.89
    -0.48 (-0.73%)
     
  • Gold

    1,847.00
    +8.90 (+0.48%)
     
  • Silver

    27.64
    +0.27 (+1.00%)
     
  • EUR/USD

    1.2143
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.6350
    0.0000 (0.00%)
     
  • Vix

    20.78
    -2.35 (-10.16%)
     
  • GBP/USD

    1.4082
    -0.0020 (-0.14%)
     
  • USD/JPY

    109.2460
    -0.1010 (-0.09%)
     
  • BTC-USD

    45,333.35
    -3,750.51 (-7.64%)
     
  • CMC Crypto 200

    1,262.40
    -96.16 (-7.08%)
     
  • FTSE 100

    7,003.62
    -39.99 (-0.57%)
     
  • Nikkei 225

    27,824.83
    -259.67 (-0.92%)
     

FDA Authorizes Two Vial Presentations For Moderna's COVID-19 Vaccine

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • The FDA approved new vials from Moderna Inc (NASDAQ: MRNA) that can contain up to 15 doses each, compared with the designed to hold ten doses.

  • Additionally, regulators said providers could safely extract up to 11 doses from the original 10-dose vials.

  • The U.S. Emergency Use Authorization label allows for vaccine vials to remain at room temperature conditions for a longer period (total of 24 hours from the previous 12 hours).

  • The dosing updates should help bolster the U.S. supplies and speed vaccinations as the U.S. nears 100 million inoculations against COVID-19. President Joe Biden has vowed to provide enough shots to vaccinate all U.S. adults by late May.

  • Moderna said it plans to begin shipping the new 15-dose vials in the coming weeks.

  • Price Action: MRNA shares are trading 2.3% higher at $134 in the premarket session on the last check Monday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.